• Sulfo-NHS-Biotin: Water-Soluble Amine-Reactive Protein La...

  2026-03-26

  Sulfo-NHS-Biotin is a benchmark water-soluble biotinylation reagent for selective, irreversible labeling of primary amines on proteins. Its sulfonated NHS ester chemistry delivers high aqueous solubility and membrane-impermeant specificity, enabling robust cell surface protein labeling and downstream affinity-based workflows. APExBIO’s A8001 kit exemplifies this utility, supporting precise and high-yield biotinylation in biochemical research.

• TG003: Selective Cdc2-like Kinase Inhibitor for Alternati...

  2026-03-26

  TG003 is a highly selective Cdc2-like kinase (Clk) family inhibitor with nanomolar potency. It enables precise modulation of alternative splicing and is a critical tool in cancer and neuromuscular disease research, including studies addressing platinum resistance and exon-skipping strategies.

• E-64d: Membrane-Permeable Cysteine Protease Inhibitor for...

  2026-03-25

  E-64d is a synthetic, membrane-permeable cysteine protease inhibitor used for selective inhibition of calpain and lysosomal cathepsins in apoptosis and neuroprotection research. With high cell permeability and irreversible inhibition, E-64d enables precise dissection of protease-mediated pathways in cell death and disease models.

• E-64d (SKU A1903): Reliable Cysteine Protease Inhibition ...

  2026-03-25

  This article provides biomedical researchers and lab technicians with scenario-driven, evidence-based strategies for deploying E-64d (SKU A1903) in cell viability, apoptosis, and neuroprotection assays. Drawing on peer-reviewed literature, quantitative data, and practical workflow insights, it demonstrates how E-64d’s membrane-permeable, irreversible inhibition of calpain and cathepsins enhances reproducibility and data quality. Explore the scientific rationale, protocol guidance, and product selection criteria that position E-64d as a leading tool for regulated cell death research.

• Mechanistic Insight and Translational Strategy: Harnessin...

  2026-03-24

  This thought-leadership article synthesizes mechanistic, experimental, and translational perspectives on E-64—a potent, irreversible L-trans-epoxysuccinyl peptide cysteine protease inhibitor. We explore its role in decoding protease signaling, optimizing experimental design, and accelerating innovation in cancer and inflammation research. Building on recent literature and competitive guidance, we provide strategic recommendations for translational researchers aiming to deploy E-64 in cutting-edge workflows.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Pr...

  2026-03-24

  Explore the unique advantages of the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) for protein preservation during extraction and sensitive phosphorylation analysis. Discover deep scientific insights into its mechanism and applications for protease activity regulation in complex workflows.

• E-64 and the Systems Biology of Cysteine Protease Inhibition

  2026-03-23

  Discover the pivotal role of E-64 as an L-trans-epoxysuccinyl peptide cysteine protease inhibitor in dissecting protease signaling pathways and disease models. This article uniquely explores E-64’s systems-level impact on cathepsin and calpain inhibition, integrating recent in vivo findings and its advanced utility in cancer research.

• E-64d: A Membrane-Permeable Cysteine Protease Inhibitor f...

  2026-03-23

  E-64d empowers researchers to dissect regulated cell death pathways with unparalleled specificity, offering robust intracellular cysteine protease inhibition for apoptosis, platelet, and neuroprotection studies. Its membrane-permeability and irreversible mechanism enable precise modulation of calpain and cathepsin activity, making E-64d the go-to choice for experiments where lysosomal and cytosolic protease control is critical.

• E-64d: A Next-Generation Tool for Dissecting Cysteine Pro...

  2026-03-22

  Explore how E-64d, a membrane-permeable cysteine protease inhibitor, redefines experimental precision in apoptosis and neurodegeneration research. This article delves into advanced mechanistic insights, novel applications, and the emerging role of E-64d in modeling lysosome-dependent cell death.

• TG003: Selective Clk1 Inhibitor for Alternative Splicing ...

  2026-03-21

  TG003 is a potent, selective Cdc2-like kinase (Clk) inhibitor used for dissecting alternative splicing and Clk-mediated phosphorylation pathways. As a benchmark Clk1 inhibitor, it enables precise control of splice site selection and has emerging applications in cancer and exon-skipping therapy research. This article provides structured, evidence-based insight into TG003’s mechanism, validated use-cases, and experimental integration.

• TG003: Selective Clk1/2 Inhibitor for Alternative Splicin...

  2026-03-20

  TG003 is a potent, selective Cdc2-like kinase (Clk) inhibitor that enables targeted modulation of alternative splicing and phosphorylation of serine/arginine-rich proteins. Its robust activity against Clk1 and Clk4, ATP-competitive mechanism, and proven efficacy in platinum-resistant cancer models make it indispensable for splice site selection research and therapeutic development.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Pr...

  2026-03-20

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) offers broad-spectrum, EDTA-free inhibition of serine, cysteine, acid proteases, and aminopeptidases during protein extraction. Its DMSO-based, 100X formulation ensures compatibility with phosphorylation analysis and sensitive downstream assays, making it a cornerstone for reliable protein degradation prevention.

• Sulfo-NHS-Biotin: Precision Water-Soluble Protein Labelin...

  2026-03-19

  Sulfo-NHS-Biotin stands out as a premier water-soluble biotinylation reagent, delivering robust, membrane-impermeant labeling for cell surface proteins and affinity workflows. Its rapid, amine-reactive chemistry ensures high specificity and reproducibility, empowering advanced applications from single-cell screening to immunoprecipitation. Discover how APExBIO’s Sulfo-NHS-Biotin optimizes experimental fidelity across molecular biology and proteomics.

• TG003: Selective Clk Family Kinase Inhibitor for Alternat...

  2026-03-19

  TG003 is a potent, selective Cdc2-like kinase inhibitor targeting Clk1, Clk2, and Clk4, enabling precise modulation of alternative splicing in disease models. Its nanomolar activity and robust performance make it indispensable for research in splice site selection, exon-skipping therapy, and platinum-resistant cancer mechanisms.

• E-64d: Unraveling Cysteine Protease Inhibition in Lysopto...

  2026-03-18

  Explore how E-64d, a membrane-permeable cysteine protease inhibitor, uniquely empowers the study of lysoptosis and regulated cell death across diverse biological models. This article offers an in-depth mechanistic analysis and highlights applications in neuroprotection, apoptosis, and disease research.

15935 records 1/1063 page Next 12345 下5页 Last page